IP Library Granted Patent US 8,790,710
Granted Patent B1
US 8,790,710 · App. 12/836,168 · Granted Jul 29, 2014

Topical composition comprising umbilical cord blood serum

Inventor: Alvin Needleman (Las Vegas, NV)
Assignee: Novo Solutions, MD, L.L.C.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,790,710
App. No.
12/836,168
Granted
Jul 29, 2014
Kind
B1
Abstract

Cosmetic compositions comprising umbilical cord blood serum and methods of using such compositions to impart anti-aging benefits to the skin are disclosed.

Claims (10)

1. A skin care composition for topical application to the human skin comprising an effective amount of umbilical cord blood serum wherein the cells have been removed so the umbilical cord serum is substantially free of whole cells, and further comprising a peptide selected from the group consisting of tyr-arg, acetyl hexapeptide-3, palmitoyl oligopeptide, palmitoyl tetrapeptide-7, and mixtures thereof.

2. A skin care composition for topical application to the human skin comprising an effective amount of umbilical cord blood serum wherein the cells have been removed so the umbilical cord serum is substantially free of whole cells, further comprising a biological additive selected from the group consisting of Juglans regia, Centella asiatica, Pyrus germanica extract, and mixtures thereof.

3. A skin care composition for topical application to the human skin comprising an effective amount of umbilical cord blood serum wherein the cells have been removed so the umbilical cord serum is substantially free of whole cells, further comprising a biological additive selected from the group consisting of Undaria pinnatifida and Stevia rebaudiana Bertoni, and mixtures thereof.

4. A skin care composition for topical application to the human skin comprising an effective amount of umbilical cord blood serum wherein the cells have been removed so the umbilical cord serum is substantially free of whole cells, further comprising a preservative selected from the group consisting of one or more parabens.

5. A skin care composition for topical application to the human skin comprising an effective amount of umbilical cord blood serum wherein the cells have been removed so the umbilical cord serum is substantially free of whole cells, further comprising a penetration enhancer selected from the group consisting of dimethyl isosorbide and diethyl-glycol-monoethylether.

6. A skin care composition for topical application to the human skin comprising an effective amount of umbilical cord blood serum wherein the cells have been removed so the umbilical cord serum is substantially free of whole cells, further comprising one or more skin-conditioning emollients selected from the group jojoba oil, almond oil, capric/caprylic triglyceride and mixtures thereof.

7. A skin care composition for topical application to the human skin comprising about 0.1 wt % to about 0.35 wt % umbilical cord blood serum wherein the cells have been removed so the umbilical cord serum is substantially free of whole cells, about 3 wt % to 5 wt % palmitoyl oligopeptide, about 3 wt % to about 5 wt % palmitoyl tetrapeptide-7.

8. The skin care composition of claim 7 further comprising about 2 wt % to about 3 wt % of the dipeptide tyr-arg and about 0.5 wt % to 1.5 wt % acetyl hexapeptide-3.

9. The skin care composition of claim 8 further comprising about 0.5 wt % to about 1.2 wt % phosphatidyl choline, about 0.5 wt % to about 1.5 wt % hyaluronans, and 0.01 wt % to 0.085 wt % of a preservative selected from the group consisting of methyl paraben and propyl paraben, or mixtures thereof.

10. The skin care composition of claim 9 further comprising Juglans regia, Centella asiatica, Pyrus germanica, Undaria pinnatifida , and Stevia rebaudiana Bertoni.

Assignments (4)
CHANGE OF NAME Recorded Jul 18, 2025
From: NOVO DERMA, LLC
To: NOVO DERMA, INC.
Reel/Frame 072078/0698 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 4, 2021
From: NOVO SOLUTIONS, MD, LLC
To: NOVO DERMA, LLC
Reel/Frame 058024/0902 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 16, 2011
From: RIMAR, LLC
To: NOVO SOLUTIONS, MD, L.L.C. F/K/A CELLVATION, L.L.C.
Reel/Frame 025816/0350 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 14, 2010
From: NEEDLEMAN, ALVIN
To: RIMAR, LLC.
Reel/Frame 024684/0553 →
Continuity (1)
Provisional Application 61278040 · Oct 2, 2009